Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
01/2011
01/04/2011CA2381461C Lhrh antagonists having improved solubility properties
01/04/2011CA2319672C Compounds and compositions for delivering active agents
01/04/2011CA2231916C Erythrocytes loaded with s-nitrosothiol and uses therefor
12/2010
12/30/2010US20100331420 Combination Therapies for the Treatment of Obesity
12/30/2010US20100331419 Combination Therapies for the Treatment of Obesity
12/30/2010US20100331366 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
12/30/2010US20100331343 Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors
12/30/2010US20100330210 Ghrelin production promoter
12/30/2010US20100330184 Injection vehicle for polymer-based formulations
12/30/2010US20100330168 Pharmaceutical composition based on micronized progesterone and uses thereof
12/29/2010WO2010151281A1 Methods and kits for treating joints and soft tissues
12/29/2010WO2010150837A1 Indoline derivative
12/29/2010WO2010149273A1 Pharmaceutical composition for emergency contraception
12/29/2010EP2267026A1 Albumin fusion proteins
12/29/2010EP2266665A1 Method for the improvement of islet signaling in diabetes mellitus and for its prevention
12/29/2010EP2266624A2 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
12/29/2010EP2266577A1 Multi-substitued selective androgen receptor modulators and methods of use therof
12/29/2010EP2266573A1 Fulvestrant formulation
12/29/2010EP2265629A2 Bismethylene-17 carbolactones and related uses
12/29/2010EP2265593A1 Novel 1,2,4-triazole derivatives and process of manufacturing thereof
12/29/2010CN101932311A Microparticles and pharmaceutical compositions thereof
12/29/2010CN101926997A Use of angiotensin ii receptor antagonists, especially telmisartan, in order to increase insulin sensitivity
12/29/2010CN101926826A Method for extracting active ingredients from sea horse
12/29/2010CN101926787A Application of flavone compound in protecting liver
12/29/2010CN101926783A Drug slow control releaser and preparation method thereof
12/29/2010CN101530489B Chinese medicine composition used for treating non-active stage infiltrative exophthalmos of thyroid-associated ophthalmopathy and preparation method thereof
12/29/2010CN101396357B Use of lipoamide in preventing and treating insulin resistance
12/29/2010CN101142193B Propane-1,3-dion derivative or salt thereof
12/29/2010CN101087606B Estrogen receptor modulators
12/29/2010CA2766197A1 Pharmaceutical composition for emergency contraception
12/29/2010CA2698513A1 Micronized progesterone-based pharmaceutical composition and its uses
12/28/2010US7858794 such as 5-Chloro-thiophene-2-carboxylic acid (1-acetyl-7-dimethylamino-4-methyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-amide, having follicle stimulating hormone modulatory activity, used to regulate fertility as contraceptives and for treatment of breast cancer, prostate cancer and endometriosis
12/28/2010US7858789 Affinity for somatostatin receptors; used for the treatment of acromegalia, hypophyseal adenomas or endocrine gastroenteropancreatic tumors including carcinoid syndrome; 4-(urea or thiourea substituted)-1-alkylpiperidines
12/28/2010US7858656 Controlled release formulations containing an active ingredient, preferably melatonin and the method of preparation
12/28/2010US7858091 Insulin-like growth factor binding protein specific monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, muscular and vision disorders
12/28/2010US7858085 Reducing blood glucose level in a non-obese or obese human afflicted with Type 2 diabetes by administering purified human placental alkaline phosphatase
12/23/2010WO2010147234A1 Diarylamide-spirodiamine derivative
12/23/2010WO2010146299A1 Azetidine-derived esters, preparation thereof, and therapeutic use thereof as cannabinoid receptor modulators
12/23/2010WO2010145903A1 New therapeutical uses of inecalcitol
12/23/2010WO2010145125A1 Highly purified human menopausal gonadotropins, method for preparing and uses thereof
12/23/2010WO2010122385A8 Fast-acting insulin formulation
12/23/2010US20100324104 1,2,3-triazoles as 11-beta hydroxysteroid dehydrogenase type i inhibitors
12/23/2010US20100324093 Ccr9 inhibitors and methods of use thereof
12/23/2010US20100324084 Urea derivatives of tropane, their preparation and their therapeutic application
12/23/2010US20100324076 Novel sEH Inhibitors and their Use
12/23/2010US20100324007 Oral suspension of prednisolone acetate
12/23/2010US20100324006 Hormone delivery system and method
12/23/2010US20100323999 Therapeutic Molecules and Methods-1
12/23/2010US20100323997 Novel uses
12/23/2010US20100323988 Solid citrate and tartrate salts of dpp-iv inhibitors
12/23/2010US20100323981 Treatment of statin side effects
12/23/2010US20100323964 New non-selective somatostatin analogues
12/23/2010US20100322920 Human monoclonal antibodies against CD30
12/23/2010US20100322884 Method and composition for transdermal drug delivery
12/23/2010CA2765415A1 Substituted -1,3,8-triazaspiro[4.5]decane-2,4-diones
12/23/2010CA2764830A1 Novel [3,2-c] heteroaryl steroids as glucocorticoid receptor agonists, compositions and uses thereof
12/23/2010CA2762458A1 New therapeutical uses of inecalcitol
12/22/2010EP2264173A2 Use of a double-stranded ribonucleic acid for targeted inhibition of the expression of a given target gene
12/22/2010EP2264066A2 Novel insulin derivatives
12/22/2010EP2264065A2 Novel Insulin Derivatives
12/22/2010EP2264064A1 Modified exendins and exendin agonists
12/22/2010EP2264028A1 Pyrazole compounds useful as protein kinase inhibitors
12/22/2010EP2263697A2 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
12/22/2010EP2263677A1 New therapeutical uses of inecalcitol
12/22/2010EP2263670A1 Use of angiotensin II receptor antagonists in order to increase insulin sensitivity
12/22/2010EP2262890A1 Method for generating islet beta cells from dedifferentiated exocrine pancreatic cells
12/22/2010EP1676862B1 Recombinant antibody against human insulin-like growth factor
12/22/2010EP1390037B1 Use of glucocorticoid receptor-specific antagonists for the treatment of delirium
12/22/2010CN101921772A Human antibodies that bind human IL-12 and methods for producing
12/22/2010CN101921270A Mangiferin berberine salt, preparation method thereof and use thereof
12/22/2010CN101921266A 3,4,6-triaryl-[1,3]-oxazine compound as well as preparation method and application thereof
12/22/2010CN101919984A Drug for treating hyperthyroidism and preparation method and application thereof
12/22/2010CN101919864A Tolvaptan medicinal composition and preparation method thereof
12/22/2010CN101919855A Pharmacy application of piperazine ferulate
12/22/2010CN101919839A Usage of mangiferin calcium salt taken as AMPK agonist
12/22/2010CN101919835A Application of 2-acetylamino gentisic acid to preparing insulin sensitizer
12/22/2010CN101418000B DPP-IV inhibitor derivates containing benzofuran sulfonyl ureas
12/21/2010CA2470109C Substituted phenyl naphthalenes as estrogenic agents
12/21/2010CA2468374C Glp-1 derivatives
12/16/2010WO2010144502A2 Growth hormone polypeptides and methods of making and using same
12/16/2010WO2010143803A2 New nicotinamide derivatives with anti-androgen effects, processes of preparing, and antiandrogens comprising the same
12/16/2010WO2010142705A1 Substituted 16,17-annellated steroid compounds for use in women's healthcare
12/16/2010WO2010142060A1 Lhrh antagonist with long potency and low histamine releasing effect
12/16/2010US20100317730 Treatment for menopausal and perimenopausal vasomotor symptons
12/16/2010US20100317712 Estrogen Agonists/Antagonists For Preventing Breast Cancer
12/16/2010US20100317706 HNF4alpha MODULATORS AND METHODS OF USE
12/16/2010US20100317691 Isoquinolone compounds as subtype-selective agonists for melatonin receptors mt1 and mt2
12/16/2010US20100317581 Ipamorelin Diacetate Injection and Infusion Solutions
12/16/2010US20100317579 Controlled release formulations of octreotide
12/16/2010US20100316644 Truncated actriib-fc fusion proteins
12/16/2010CA2764252A1 Substituted 16,17-annellated steroid compounds for use in women's healthcare
12/16/2010CA2764105A1 Growth hormone polypeptides and methods of making and using same
12/15/2010EP2261235A2 Inhibitors of caspases
12/15/2010EP2261234A2 Inhibitors of caspases
12/15/2010EP2261233A2 Inhibitors of caspases
12/15/2010EP2261232A2 Inhibitors of caspases
12/15/2010EP1556345B1 Vitamin d analogues, compositions comprising said analogues and their use
12/15/2010EP1537146B1 Antibodies binding to anionic phospholipids and aminophospholipids and their use in treating viral infections
12/15/2010EP1423380B1 Pyrazole-derived kinase inhibitors and uses thereof
12/15/2010CN101918427A 15,16-methylene-17-(1'-propenyl)-17,3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 290